Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DRBEAT: Temozolomide in Conditioning for CNS Lymphoma
NCT01235793Phase 2Terminated
- Sponsor
- Cedars-Sinai Medical Center
- Start
- Oct 2010
- Primary completion
- Jul 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in central nervous system lymphoma, sponsored by Cedars-Sinai Medical Center. Started Oct 2010; status: terminated.
02
Drugs
temozolomide
03
Conditions
central nervous system lymphoma
Beyond the preview
Go deeper on NCT01235793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01235793.